Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v3.19.2
CONSOLIDATED BALANCE SHEETS - USD ($)
May 31, 2019
Aug. 31, 2018
Current    
Cash and cash equivalents $ 1,995,842 $ 1,727,184
Marketable securities (Note 19) 74,840 10,151
Accounts and other receivables (Note 6) 225,834 265,751
Inventory (Note 7) 188,275 87,233
Prepaid expenses (Note 18) 122,808 193,732
Total Current Assets 2,607,599 2,284,051
Patents (Note 8) 242,748 146,538
Property & equipment (Note 9) 606,751 1,237
Total Noncurrent Assets 849,499 147,775
TOTAL ASSETS 3,457,098 2,431,826
Current    
Accounts payable and accrued liabilities (Note 10) 111,298 35,785
Due to related parties (Note 15) 20,995 7,855
Total Current Liabilities 132,293 43,640
TOTAL LIABILITIES 132,293 43,640
STOCKHOLDERS' EQUITY    
Share Capital Authorized: 220,000,000 common voting shares with a par value of $0.001 per share Issued and outstanding: 78,437,134 common shares at May 31, 2019 and 75,533,471 common shares at August 31, 2018 78,437 75,533
Additional paid-in capital 25,890,921 22,095,682
Accumulated other comprehensive loss   (14,247)
Deficit (22,789,954) (19,768,782)
Equity attributable to shareholders 3,179,404 2,388,186
Non-controlling Interest 145,401  
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 3,457,098 $ 2,431,826